Real-World Experience with TRK Inhibitors in Patients with Lung and Colon Cancers

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Video Categories: NTRK Gene Fusions

Dr Mary Fidler of Rush University Medical Center, Chicago, IL, and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, describe their practical experiences with TRK inhibitors in patients with lung cancer and colorectal cancer.

November 24, 2014

How to Better Establish Clinical Utility for Tests in Personalized Medicine

Dr. Gary Palmer discusses the different profile of tumors and how to make findings as general as possible to better treat the patient.

January 20, 2016

Discussing the Results of BBI608 Combined with Another Therapeutic Agent

Dr Wainberg and Dr Gerson talk about the results of using investigational agent BBI608 combined with another drug that is used as a standard of care.